(Note: this is distinct from the separate TRANSCEND-T2D program below, which targets diabetes specifically rather than obesity-with-diabetes.) TRIUMPH-3: Obesity with Established Cardiovascular Disease Ongoing, results expected later 2026
An additional recent study found that GLP-1 action on human pancreatic islet alpha-cells was mediated independently of any paracrine signalling, as preventing insulin and somatostatin signalling did not affect the inhibition of glucagon secretion
When your liver is clogged from fat, it creates stress, depletes glutathione, and impairs vitamin D activation
Similarly, semaglutide has been implicated in ischemic colitis in patients without any vascular risk factors [3]
The Next Step in Your Longevity Journey If you are exploring advanced strategies to reduce visceral fat and optimize metabolic health, the next step is personalization